WallStreetZenWallStreetZen

NASDAQ: LUCD
Lucid Diagnostics Inc Stock Ownership - Who owns Lucid Diagnostics?

Insider buying vs selling

Have Lucid Diagnostics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Pavmed Inc10% Owner2022-11-301,145,086$1.84
$2.10MBuy
Pavmed Inc10% Owner2022-11-30221,952$2.48
$550.00kBuy
Pavmed Inc10% Owner2022-11-30197,656$2.78
$550.08kBuy
Pavmed Inc10% Owner2022-11-301,145,086$1.84
$2.10MBuy
Pavmed Inc10% Owner2022-11-301,479,326$1.84
$2.72MBuy
Pavmed Inc10% Owner2022-11-30331,210$1.66
$550.14kBuy
Pavmed Inc10% Owner2022-11-30221,952$2.48
$550.00kBuy
Pavmed Inc10% Owner2022-11-30197,656$2.78
$550.08kBuy
Pavmed Inc10% Owner2022-11-301,479,326$1.84
$2.72MBuy
Pavmed Inc10% Owner2022-11-30331,210$1.66
$550.14kBuy

1 of 2

LUCD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LUCD insiders and whales buy or sell their stock.

LUCD Shareholders

What type of owners hold Lucid Diagnostics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Pavmed Inc71.59%31,302,420$53.84MInsider
Luminus Management LLC1.96%855,300$1.47MInstitution
Dennis M. McGrath1.43%624,400$1.07MInsider
Lishan Aklog1.43%624,400$1.07MInsider
Vanguard Group Inc0.73%319,433$549.42kInstitution
Nantahala Capital Management LLC0.60%261,664$450.06kInstitution
James L. Cox0.39%169,320$291.23kInsider
Stanley Lapidus0.31%135,456$232.98kInsider
Bridgeway Capital Management LLC0.31%135,000$232.20kInstitution
Shaun Oneil0.27%120,000$206.40kInsider

1 of 3

LUCD vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LUCD4.04%76.00%Net Buying
OSA7.93%16.54%
DCTH11.96%10.47%Net BuyingNet Buying
VANI3.11%96.89%Net BuyingNet Buying
XTNT38.43%61.57%Net Buying

Lucid Diagnostics Stock Ownership FAQ

Who owns Lucid Diagnostics?

Lucid Diagnostics (NASDAQ: LUCD) is owned by 4.04% institutional shareholders, 76.00% Lucid Diagnostics insiders, and 19.96% retail investors. Pavmed Inc is the largest individual Lucid Diagnostics shareholder, owning 31.30M shares representing 71.59% of the company. Pavmed Inc's Lucid Diagnostics shares are currently valued at $55.72M.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.